prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - (αιμοσυγκολλητίνη και νευραμινιδάση) του στελέχους Α / Βιετνάμ / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - Εμβόλια - Ενεργός ανοσοποίηση έναντι του υποτύπου h5n1 του ιού της γρίπης Α. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
rivastigmine 1 a pharma
1 a pharma gmbh - rivastigmine - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - Συμπτωματική θεραπεία της ήπιας έως μέτριας μορφής άνοιας του alzheimer. Συμπτωματική θεραπεία της ήπιας έως μετρίως σοβαρής άνοιας σε ασθενείς με ιδιοπαθή νόσο του Πάρκινσον.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 και 5. 1 για διαθέσιμα δεδομένα σχετικά με διαφορετικούς συνδυασμούς).
timolol/novartis 0.25% w/v ey.dro.sol
novartis (hellas) a.e.b.e. - timolol - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 0.25% w/v - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
timolol/novartis 0.5% w/v ey.dro.sol
novartis (hellas) a.e.b.e. - timolol - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 0.5% w/v - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
desferal 500mg/vial powder for injection
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - deferoxamine mesilate - powder for injection - 500mg/vial - deferoxamine mesilate (0000138147) 500mg - deferoxamine
desferal 2g/vial powder for injection
novartis pharmaceuticals uk ltd, surrey (0000007817) frimley business park, frimley camberley, surrey, gu16 7sr - deferoxamine mesilate - powder for injection - 2g/vial - deferoxamine mesilate (0000138147) 2g - deferoxamine
lomir 2.5mg tablets
novartis pharmaceuticals uk ltd, surrey - isradipine - tablets - 2.5mg - 0075695931 - isradipine - 2.5 mg - isradipine
lomir sro
novartis pharmaceuticals uk ltd, surrey - isradipine - sustained release capsules - 5mg - 0075695931 - isradipine - 5 mg - isradipine
pancoran 5mg/24hrs διαδερμικο εμπλαστρο
novartis (hellas) a.e.b.e. (0000003027) 12ο χλμ. Εθν.οδού Νο1,, 144 51, Μεταμόρφωση Αττικής, 144 51 - glyceryl trinitrate - ΔΙΑΔΕΡΜΙΚΟ ΕΜΠΛΑΣΤΡΟ - 5mg/24hrs - 0000055630 glyceryl trinitrate 25.000000 mg - glyceryl trinitrate